Literature DB >> 26341826

Hepatocellular carcinoma and lifestyles.

Uttara Saran1, Bostjan Humar2, Philippe Kolly1, Jean-François Dufour3.   

Abstract

The majority of hepatocellular carcinoma occurs over pre-existing chronic liver diseases that share cirrhosis as an endpoint. In the last decade, a strong association between lifestyle and hepatocellular carcinoma has become evident. Abundance of energy-rich food and sedentary lifestyles have caused metabolic conditions such as obesity and diabetes mellitus to become global epidemics. Obesity and diabetes mellitus are both tightly linked to non-alcoholic fatty liver disease and also increase hepatocellular carcinoma risk independent of cirrhosis. Emerging data suggest that physical activity not only counteracts obesity, diabetes mellitus and non-alcoholic fatty liver disease, but also reduces cancer risk. Physical activity exerts significant anticancer effects in the absence of metabolic disorders. Here, we present a systematic review on lifestyles and hepatocellular carcinoma.
Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AMPK; Diabetes; Exercise; Insulin; Liver cancer; Obesity; mTOR

Mesh:

Substances:

Year:  2015        PMID: 26341826     DOI: 10.1016/j.jhep.2015.08.028

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  38 in total

Review 1.  Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.

Authors:  Helen L Reeves; Marco Y W Zaki; Christopher P Day
Journal:  Dig Dis Sci       Date:  2016-02-26       Impact factor: 3.199

Review 2.  Environmental health in the biology century: Transitions from population to personalized prevention.

Authors:  John D Groopman
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-20

3.  Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E.

Authors:  Ning Ma; Yanqi Hou; Heidi Coia; Marcin D Dyba; Ying Fu; M Idalia Cruz; Carlos Benitez; Garrett T Graham; Justine N McCutcheon; Yun-Ling Zheng; Bing Sun; Bhaskar V Kallakury; Junfeng Ma; Hong-Bin Fang; Deborah L Berry; Vinona Muralidaran; Fung-Lung Chung
Journal:  Cancer Prev Res (Phila)       Date:  2018-08-21

Review 4.  2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Anil Arora; Radha K Dhiman; Rakesh Aggarwal; Anil C Anand; Prashant Bhangui; Yogesh K Chawla; Siddhartha Datta Gupta; Vinod K Dixit; Ajay Duseja; Naveen Kalra; Premashish Kar; Suyash S Kulkarni; Rakesh Kumar; Manoj Kumar; Ram Madhavan; V G Mohan Prasad; Amar Mukund; Aabha Nagral; Dipanjan Panda; Shashi B Paul; Padaki N Rao; Mohamed Rela; Manoj K Sahu; Vivek A Saraswat; Samir R Shah; Praveen Sharma; Sunil Taneja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2019-09-23

5.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

6.  Physical Activity and the Risk of Liver Cancer: A Systematic Review and Meta-Analysis of Prospective Studies and a Bias Analysis.

Authors:  Sebastian E Baumeister; Michael F Leitzmann; Jakob Linseisen; Sabrina Schlesinger
Journal:  J Natl Cancer Inst       Date:  2019-11-01       Impact factor: 13.506

7.  A six-miRNA signature as a novel biomarker for improving prediction of prognosis and patterns of immune infiltration in hepatocellular carcinoma.

Authors:  Zhitao Chen; Lele Zhang; Chenchen Ding; Kuiwu Ren; Dalong Wan; Shengzhang Lin
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 8.  Developing dietary interventions as therapy for cancer.

Authors:  Samuel R Taylor; John N Falcone; Lewis C Cantley; Marcus D Goncalves
Journal:  Nat Rev Cancer       Date:  2022-05-25       Impact factor: 69.800

9.  Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma.

Authors:  Alexander Gerbes; Fabien Zoulim; Herbert Tilg; Jean-François Dufour; Jordi Bruix; Valérie Paradis; Riad Salem; Markus Peck-Radosavljevic; Peter R Galle; Tim F Greten; Jean-Charles Nault; Matias A Avila
Journal:  Gut       Date:  2017-11-17       Impact factor: 23.059

10.  Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.

Authors:  Joo Hyun Oh; Hye Won Lee; Dong Hyun Sinn; Jun Yong Park; Beom Kyung Kim; Seung Up Kim; Do Young Kim; Sang Hoon Ahn; Wonseok Kang; Geum-Youn Gwak; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Yong-Han Paik
Journal:  Hepatol Int       Date:  2021-07-14       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.